| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RPRX | Class A Ordinary Shares | Sale | -$1.17M | -41.7K | -1.49% | $28.01 | 2.75M | Dec 27, 2023 | See Footnotes | F1, F2, F3 |
| transaction | RPRX | Class A Ordinary Shares | Sale | -$5.92M | -210K | -7.62% | $28.20 | 2.54M | Dec 28, 2023 | See Footnotes | F2, F3, F7 |
| holding | RPRX | Class A Ordinary Shares | 7.8M | Dec 27, 2023 | See Footnotes | F3, F4 | |||||
| holding | RPRX | Class A Ordinary Shares | 22.2M | Dec 27, 2023 | See Footnotes | F3, F5 | |||||
| holding | RPRX | Class A Ordinary Shares | 50K | Dec 27, 2023 | See Footnotes | F3, F6 | |||||
| holding | RPRX | Class A Ordinary Shares | 7.75K | Dec 27, 2023 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.00 to $28.06 per share, inclusive. The Reporting Persons undertake to provide to Royalty Pharma plc, any security holder of Royalty Pharma plc, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F2 | Reflects securities held directly by Avara Management Ltd. Avara Management Ltd is wholly-owned by M. Germano Giuliani. |
| F3 | The Reporting Person may be deemed to beneficially own the securities reported herein directly or indirectly controlled by him, but such Reporting Person (other than the direct holder to the extent of his direct holdings) disclaims beneficial ownership of such securities, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Person is the beneficial owner of any securities reported herein or is subject to Section 16. |
| F4 | Reflects securities held directly by Skyeline Management Ltd. Skyeline Management Ltd is wholly-owned by Avara Management Ltd. Avara Management Ltd is wholly-owned by M. Germano Giuliani. |
| F5 | Reflects securities held directly by MGG Strategic SICAF SIF S.A. - MGG Strategic, a Luxembourg company ("MGG Strategic"). MGG Strategic is a sub-fund managed and administered by MGG Strategic SICAF SIF S.A. ("MGG SICAF"). A board of directors consisting of M. Germano Giuliani, Achille G. Severgnini, Marco Sterzi and Franco Toscano has voting and dispositive power over the securities managed by MGG SICAF. Each member of the board disclaims beneficial ownership over such shares. MGG SICAF is owned by the MGG Trust of which M. Germano Giuliani is the beneficiary. The MGG Trust is the 100% economic owner of the shares held by MGG Strategic. M. Germano Giuliani disclaims beneficial ownership over the shares beneficially owned by MGG Strategic. The trustee of the MGG Trust is GISEV Trustees Limited. The protector of the MGG Trust is Achille G. Severgnini, who has the power to remove and replace the trustee of the MGG Trust. |
| F6 | Reflects securities held by the spouse of M. Germano Giuliani. |
| F7 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.00 to $28.47 per share, inclusive. The Reporting Persons undertake to provide to Royalty Pharma plc, any security holder of Royalty Pharma plc, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |